Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleCELLULAR AND MOLECULAR

Transcriptional Regulation of the Human CYP2A6 Gene

Marià Pitarque, Cristina Rodríguez-Antona, Mikael Oscarson and Magnus Ingelman-Sundberg
Journal of Pharmacology and Experimental Therapeutics May 2005, 313 (2) 814-822; DOI: https://doi.org/10.1124/jpet.104.081570
Marià Pitarque
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cristina Rodríguez-Antona
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mikael Oscarson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Magnus Ingelman-Sundberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Nicotine C-oxidation is primarily catalyzed by CYP2A6 in humans. This enzymatic activity exhibits a large interindividual variability, which to a great extent is caused by genetic polymorphisms in the CYP2A6 gene. There are large interindividual differences in CYP2A6 mRNA and protein levels, but little is known about the transcriptional regulation of CYP2A6, which can, e.g., explain such differences. Using transient transfections of 5′-deleted CYP2A6 promoter constructs in human hepatoma B16A2 cells, we show that maximal promoter activity was harbored in the sequence spanning from –112 to –61. Putative response elements for the transcription factors hepatocyte nuclear factor-4 (HNF-4)α, CCAAT-box/enhancer binding protein (C/EBP)α, C/EBPβ, and octamer transcription factor-1 (Oct-1) were identified in this region, and electrophoretic mobility shift assays showed that these transcription factors bind to the predicted elements. To determine the relevance of these sites, expression vectors for these transcription factors were cotransfected with CYP2A6 promoter constructs in HepG2 cells. HNF-4α, C/EBPα, and Oct-1 exerted an activating effect, whereas overexpression of C/EBPβ reduced CYP2A6 promoter activity. To confirm the importance of these sites in vivo, mutated CYP2A6 reporter constructs were injected into mouse liver. Mutation of either HNF-4 or C/EBP-Oct-1 motifs significantly decreased promoter activity, 52 and 26% of wildtype, respectively, whereas when both motifs were mutated the activity in mice decreased to 14% of wild type. In conclusion, the data indicate that the constitutive hepatic expression of CYP2A6 is governed by an interplay between the transcription factors HNF-4α, C/EBPα, C/EBPβ, and Oct-1. These results will be important for the identification of new polymorphisms affecting CYP2A6 gene expression.

Footnotes

  • This study was supported in part by National Institutes of Health, National Institute of General Medical Sciences Grant 1-R01 GM60548-01A2 and the Swedish Research Council and the Swedish Cancer Foundation. M.P. was granted a postdoctoral fellowship from the Institute of Environmental Medicine, Karolinska Institutet. C.R.-A. was a recipient of a Marie Curie fellowship from the European Union Community program Quality of Life and Management of Living Resources under contract number QLG5-CT-2002-51733.

  • doi:10.1124/jpet.104.081570.

  • ABBREVIATIONS: P450, cytochrome P450; SNP, single nucleotide polymorphism; HNF, hepatocyte nuclear factor; EMSA, electrophoretic mobility shift assay; C/EBP, CCAAT-box/enhancer binding protein; DR, direct repeat; Oct-1, octamer transcription factor-1; CAR, constitutive androstane receptor; DBP, D-box binding protein; RXR, retinoid-X-receptor; LAP, liver-enriched transcriptional activating protein; LIP, liver-enriched transcriptional inhibitory protein; NF-I, nuclear factor I; PCR, polymerase chain reaction.

  • ↵1 These authors contributed equally to the experimental work and preparation of the manuscript.

  • ↵2 Current address: Department of Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.

    • Received December 3, 2004.
    • Accepted January 21, 2005.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 387 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 387, Issue 1
1 Oct 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Transcriptional Regulation of the Human CYP2A6 Gene
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleCELLULAR AND MOLECULAR

Transcriptional Regulation of the Human CYP2A6 Gene

Marià Pitarque, Cristina Rodríguez-Antona, Mikael Oscarson and Magnus Ingelman-Sundberg
Journal of Pharmacology and Experimental Therapeutics May 1, 2005, 313 (2) 814-822; DOI: https://doi.org/10.1124/jpet.104.081570

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleCELLULAR AND MOLECULAR

Transcriptional Regulation of the Human CYP2A6 Gene

Marià Pitarque, Cristina Rodríguez-Antona, Mikael Oscarson and Magnus Ingelman-Sundberg
Journal of Pharmacology and Experimental Therapeutics May 1, 2005, 313 (2) 814-822; DOI: https://doi.org/10.1124/jpet.104.081570
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Role of ERK1/2 Signaling in Stc2-Mediated Protection
  • Topical arsenicals and transcriptional changes in the kidney
  • Effect of CBG and EAA on UVA-irradiated keratinocytes
Show more Cellular and Molecular

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics